A scientific seminar on the use, effectiveness and clinical role of denosumab in treating musculoskeletal tumors, particularly giant cell tumors of bone, was held at the National Institute of Traumatology and Orthopaedic Rehabilitation (NITOR) in the capital on Tuesday.

The seminar was organised by NITOR’s Orthopaedic Oncology Unit at Conference Hall-2 of the hospital at 8:00 am. Specialist physicians took part in the programme, sharing scientific knowledge and clinical experience on the application of denosumab, its role in treatment management and contemporary approaches to tumor care.

NITOR Director Professor Dr Md Abul Kenan presided over the seminar, while Medical Officer Dr Nazmul Hasan presented the keynote paper. The expert panel included Professor Dr Mohammad Wakil Ahmed, Professor Dr Mohammad Sirajus Saleheen, Professor Dr Muhammad Saeed Mahmud, Professor Dr Md Masudur Rahman, Professor Dr Md Mizanur Rahman, Professor Dr Md Abu Awal Shamim, Professor Dr Md Kamruzzaman and Professor Dr Md Tofayel Hossain. Assistant Professor Dr Golam Mahmud Suhas of Red Unit-1 moderated the session. During the scientific discussions, participants examined the application of denosumab in treating musculoskeletal tumors, particularly giant cell tumors of bone, as well as its potential role in treatment planning and patient management. The specialists shared their experiences and discussed existing treatment methods and practical considerations associated with the use of the drug.

The seminar also provided an opportunity for physicians to exchange views on advances in tumor treatment, emerging clinical experiences and scientific findings relevant to orthopaedic oncology.